Funded Startups in Sioux Falls
Recent Sioux Falls rounds shown span from 2020-07-17 (SAB Biotherapeutics, $14M) to 2026-05-20 (Datavyne, $60K), with six of the seven entries landing in 2…
Recent Sioux Falls rounds shown span from 2020-07-17 (SAB Biotherapeutics, $14M) to 2026-05-20 (Datavyne, $60K), with six of the seven entries landing in 2026 (2026-01-20 through 2026-05-20). The disclosed-size distribution is highly uneven: SAB Biotherapeutics closed a $85M round on 2026-03-17, which is the only disclosed amount above $50M, while several other disclosed rounds cluster much lower at $5M (CoinLion on 2026-05-07; Prismatic on 2026-01-20) and $920K (Face It TOGETHER on 2026-04-02), plus $2M (Inanovate on 2022-10-06). Sector-wise, biotechnology appears in three of seven rows (SAB Biotherapeutics twice, Inanovate once), while the remaining entries split across data and analytics (Datavyne, Prismatic) and blockchain/cryptocurrency (CoinLion) and education (Face It TOGETHER). Stage labels are also skewed: five of the seven rows show “Series Unknown” (CoinLion, Face It TOGETHER, SAB Biotherapeutics in 2026, Prismatic, Inanovate), limiting precision on stage progression even as the 2026 rounds concentrate in a narrow window.
Most recent rounds
7 shownRelated listings
Frequently asked
What’s the largest disclosed round among these Sioux Falls entries, and how does it compare to the rest?
SAB Biotherapeutics’ $85M round on 2026-03-17 is the only disclosed amount above $50M, dwarfing the next-largest disclosed rounds: $14M (SAB Biotherapeutics on 2020-07-17) and $5M (CoinLion on 2026-05-07 and Prismatic on 2026-01-20).
Do the most recent closings cluster tightly in time?
Yes. Six of the seven rows are dated in 2026, running from 2026-01-20 (Prismatic, $5M) through 2026-05-20 (Datavyne, $60K). The only non-2026 out of the seven is Inanovate in 2022-10-06 ($2M) plus a 2020-07-17 SAB Biotherapeutics round ($14M).
Which sectors are over-represented in this set?
Biotechnology stands out with 3 of 7 rows: SAB Biotherapeutics (2026-03-17, $85M; 2020-07-17, $14M) and Inanovate (2022-10-06, $2M). The rest are singletons by category: data and analytics (Datavyne, $60K on 2026-05-20; Prismatic, $5M on 2026-01-20), blockchain/cryptocurrency (CoinLion, $5M on 2026-05-07), and education (Face It TOGETHER, $920K on 2026-04-02).
How dominant is “Series Unknown” in these records, and which specific entries carry it?
Five of seven rows list “Series Unknown” (CoinLion on 2026-05-07, Face It TOGETHER on 2026-04-02, SAB Biotherapeutics on 2026-03-17, Prismatic on 2026-01-20, and SAB Biotherapeutics on 2020-07-17 shows a blank series). The remaining two rows are Datavyne marked “Seed” ($60K on 2026-05-20) and Inanovate marked “Venture - Series Unknown” ($2M on 2022-10-06).
Are there outliers that look materially different from the rest of the disclosed amounts?
SAB Biotherapeutics’ $85M on 2026-03-17 is a clear high outlier versus the $5M pair (CoinLion on 2026-05-07; Prismatic on 2026-01-20) and the smaller disclosed rounds at $920K (Face It TOGETHER on 2026-04-02) and $60K (Datavyne on 2026-05-20). On the low end, Inanovate’s $2M on 2022-10-06 sits materially below the $5M cluster.
Which entries are within the most recent 90 days covered by this page’s data?
Using the latest date shown (2026-05-20), entries within roughly the prior 90 days include Datavyne (2026-05-20, $60K), CoinLion (2026-05-07, $5M), Face It TOGETHER (2026-04-02, $920K), SAB Biotherapeutics (2026-03-17, $85M), and Prismatic (2026-01-20, $5M). Inanovate (2022-10-06, $2M) and the older SAB Biotherapeutics round (2020-07-17, $14M) fall outside that window.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.